Evidence map›Paper›PMID 40284355›Full record

ReviewPolymers2025

Biomaterial-Based Additive Manufactured Composite/Scaffolds for Tissue Engineering and Regenerative Medicine: A Comprehensive Review.

Jigar Vyas, Nensi Raytthatha, Puja Vyas, Bhupendra G Prajapati, Pimpon Uttayarat, Sudarshan Singh, Chuda Chittasupho

Abstract readReview
In one paragraph

Review in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jigar VyasKrishna School of Pharmacy & Research, Dr. Kiran and Pallavi Global University, Varnama, Vadodara 391240, Gujarat, India.
Nensi RaytthathaKrishna School of Pharmacy & Research, Dr. Kiran and Pallavi Global University, Varnama, Vadodara 391240, Gujarat, India.
Puja VyasSigma Institute of Pharmacy, Sigma University, Vadodara 390019, Gujarat, India.
Bhupendra G PrajapatiShree S.K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva 3840212, Gujarat, India.ORCID 0000-0001-8242-4541
Pimpon UttayaratNuclear Technology Research and Development Center, Thailand Institute of Nuclear Technology (Public Organization), Nakhon Nayok 26120, Thailand.ORCID 0000-0002-8196-2185
Sudarshan SinghOffice of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-7929-3322
Chuda ChittasuphoFaculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-0696-9969

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Additive manufacturing (AM), also referred to as three-dimensional printing/printed (3DP), has emerged as a transformative approach in the current design and manufacturing of various biomaterials for the restoration of damaged tissues inside the body. This advancement has greatly aided the development of customized biomedical devices including implants, prosthetics, and orthotics that are specific to the patients. In tissue engineering (TE), AM enables the fabrication of complex structures that promote desirable cellular responses in the regeneration of tissues. Since the choice of biomaterials plays a vital role in scaffold performance as well as cellular responses, meticulous material selection is essential in optimizing the functionality of scaffolds. These scaffolds often possess certain characteristics such as biodegradability, biocompatibility, biomimicry, and porous structure. To this end, polymers such as chitosan, collagen, alginate, hyaluronic acid, polyglycolic acid, polylactic acid, and polycaprolactone have been extensively investigated in the fabrication of tissue-engineered scaffolds. Furthermore, combinations of biomaterials are also utilized to further enhance the scaffolds' performance and functionality. This review discusses the principle of AM and explores recent advancements in AM technologies in the development of TE and regenerative medicine. In addition, the applications of 3DP, polymer-based scaffolds will be highlighted.

Indexed as

3D printingadditive manufacturingbiomaterialsregenerative medicinescaffoldtissue engineering

Identifiers

PMID40284355
PMCPMC12030672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.